Effect of Exercise Stress Testing on Peripheral Gene Expression Using Corus CAD (or ASGES) Diagnostic Test
| Status: | Completed |
|---|---|
| Conditions: | Angina, Peripheral Vascular Disease, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 45 - 75 |
| Updated: | 2/2/2019 |
| Start Date: | September 2011 |
| End Date: | November 2013 |
Effect of Exercise Stress Testing on Peripheral Gene Expression Using Corus CAD Diagnostic Test (Age, Sex, Gene Expression Score ASGES).
This is a prospective, single-center study that aims to evaluate the acute and delayed effect
of exercise stress testing on the peripheral gene expression (PGE) levels using a predefined
gene set established in the Corus CAD (Age/Sex/Gene Expression score - ASGES) test in subject
with known obstructive coronary artery disease (CAD) and in control subjects (without known
CAD).
of exercise stress testing on the peripheral gene expression (PGE) levels using a predefined
gene set established in the Corus CAD (Age/Sex/Gene Expression score - ASGES) test in subject
with known obstructive coronary artery disease (CAD) and in control subjects (without known
CAD).
This is a prospective, single-center study. This protocol is a pilot study to investigate the
effects of "acute" exercise (by exercise stress testing; modified Bruce protocol) on
peripheral gene expression (PGE) levels as measured by Corus CAD score (Age/Sex/Gene
Expression score - ASGES). Subjects will have blood sampling at baseline, at peak exercise,
within 30 to 60 minutes post-exercise, at 24-36 hours post-exercise. The study will be
stratified by presence of CAD and gender. An equal number of subjects with known CAD and
normal controls will be enrolled. Equally, an equal number of men and women will be included.
A screening CBC and HgbA1c will be performed to ensure the subject meets the intended use
instruction for Corus CAD (ASGES). Data collection will include presence or absence of ECG
ischemia with testing, as well as heart rate and blood pressure response to exercise with
other ECG and dynamic variables. There will be four blood samples taken per subject as shown
in the figure below.
effects of "acute" exercise (by exercise stress testing; modified Bruce protocol) on
peripheral gene expression (PGE) levels as measured by Corus CAD score (Age/Sex/Gene
Expression score - ASGES). Subjects will have blood sampling at baseline, at peak exercise,
within 30 to 60 minutes post-exercise, at 24-36 hours post-exercise. The study will be
stratified by presence of CAD and gender. An equal number of subjects with known CAD and
normal controls will be enrolled. Equally, an equal number of men and women will be included.
A screening CBC and HgbA1c will be performed to ensure the subject meets the intended use
instruction for Corus CAD (ASGES). Data collection will include presence or absence of ECG
ischemia with testing, as well as heart rate and blood pressure response to exercise with
other ECG and dynamic variables. There will be four blood samples taken per subject as shown
in the figure below.
Inclusion Criteria:
1. Ages 45-75 years old
2. Able to perform an adequate exercise stress test
3. Subjects with no known CAD and subjects with known CAD subjects
Exclusion Criteria:
1. Known severe CAD that will be unsafe to exercise stress patient
2. Current MI or high-risk acute coronary syndrome (including high-risk unstable angina
3. NYHA class III or IV congestive heart failure
4. Severe regurgitant or stenotic cardiac valvular lesion
5. Severe left ventricular systolic dysfunction
6. Active systemic infection in the preceding 2 months or chronic infection (e.g. HIV,
Hepatitis B or C, Tuberculosis)**.
7. Protocol-specified rheumatologic, autoimmune or hematologic conditions
8. Known or suspected diabetes mellitus or documented Hemoglobin A1C (A test for people
with diabetes that monitors their average blood sugar levels over a period of two to
three months) percent within last 6 months; presume normal HgbA1c (used as a standard
tool to determine blood sugar control for patients with diabetes.) if none documented.
9. Total WBC 11,000/ul from a CBC drawn within 7 days of enrollment
10. Inadequate exercise stress test.
11. Recipient of any organ transplant
12. Immunosuppressive or immunomodulatory therapy including any dose of systemic
corticosteroids in the preceding two months
13. Chemotherapy in the preceding year
14. Major surgery in the preceding 2 months
15. Blood or blood product transfusion in the preceding 2 months
We found this trial at
1
site
Click here to add this to my saved trials
